Redmile Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-336,759
Closed -$5.13M 59
2016
Q3
$5.13M Sell
336,759
-634,806
-65% -$25.7M 0.41% 37
2016
Q2
$37.7M Sell
971,565
-84,494
-8% -$3.04M 3.6% 10
2016
Q1
$29.4M Sell
1,056,059
-167,658
-14% -$5.59M 3.04% 12
2015
Q4
$65.8M Sell
1,223,717
-98,875
-7% -$4.99M 5.08% 5
2015
Q3
$53M Buy
1,322,592
+712,421
+117% +$23.2M 4.01% 8
2015
Q2
$19.5M Sell
610,171
-58,500
-9% -$1.48M 1.6% 25
2015
Q1
$16M Sell
668,671
-322,139
-33% -$7.22M 1.43% 30
2014
Q4
$17.5M Sell
990,810
-12,686
-1% -$198K 1.9% 20
2014
Q3
$13.8M Buy
1,003,496
+24,050
+2% +$361K 1.69% 27
2014
Q2
$16.5M Sell
979,446
-21,614
-2% -$357K 2.01% 25
2014
Q1
$18.2M Buy
+1,001,060
New +$18.1M 2.17% 20

Other funds holding ITCI